Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.7.2020 for a period of 24 months until 30.6.2022, with options to extend up to a maximum period of 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Bio Products Laboratory Ltd | 07343036 | ~£334,400,000 estimated from lot values | LOBBYIST Garnish Hall Enterprises Ltd (1 quarter) |
| Biotest (UK) Ltd | 01126745 | ~£334,400,000 estimated from lot values | - |
| Grifols UK Ltd | 01456099 | ~£334,400,000 estimated from lot values | - |
| Novo Nordisk Ltd | 01118740 | ~£334,400,000 estimated from lot values | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Octapharma Ltd | 02372699 | ~£334,400,000 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£334,400,000 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£334,400,000 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Shire Pharmaceuticals Limited | 02031674 | ~£334,400,000 estimated from lot values | - |
| Swedish Orphan Biovitrum Ltd (Sobi UK) | 04369760 | ~£334,400,000 estimated from lot values | - |
Government spending data: These suppliers have received £386,347,698 in 3,215 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 16 more public bodies (2018-09-13 to 2026-03-31).